Status:
RECRUITING
(Italian Migraine Registry, I-GRAINE-NEW)
Lead Sponsor:
IRCCS San Raffaele Roma
Conditions:
Migraine Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Rationale Understanding the mechanisms and evolution of migraine is hampered by its nature as a chronic "evolutionary" condition. Patients often come to migraine centers after years of disabling disea...
Eligibility Criteria
Inclusion
- Adult Patients(Age ≥ 18 years) of both sexes
- Diagnosis confirmed of episodic migraine ( \<15 days/month ) with or without aura or chronic migraine (\>15days/month) ,with or without headeche due to overuse of analgesics;
- Provision of signed and dated the Informed Consent Form before the inclusion in the study
Exclusion
- Patients affected by other forms of primary or secondary headaches or in whom the diagnosis is not certain
Key Trial Info
Start Date :
April 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 5 2026
Estimated Enrollment :
2030 Patients enrolled
Trial Details
Trial ID
NCT07163416
Start Date
April 19 2021
End Date
March 5 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Head, Irccs San Raffaele Roma S.r.l. - Unità per la cura e la ricerca su cefalee e dolore - Dipartimento di Neurologia, Via di Val di Cannuta 250, 00166 Roma (RM) - Italy
Roma, Roma, Italy, 00166